穿支动脉粥样硬化病.pptxVIP

BAD Related Ischemic Stroke;进展性卒中;进展性腔梗;Lacunar Stroke Is the Major Cause of Progressive Motor Deficits;Progressive Motor Deficits;SSSI（孤立皮层下小梗死）;Neuroimaging Markers for END in SSSI;Branch atheromatous disease and its association with progressive motor deficits;BAD;BAD;概念;BAD的病理机制;A BAD，病灶延伸到脑桥腹侧表面 B 脂质透明变性脑桥腔隙性脑梗死。;;临床表现;High-resolution MRI findings in patients withcapsular warning syndrome;Capsular warning syndrome;BAD诊断标准;Clinical Evaluation of LI and BAD;Clinical Evaluation of LI and BAD;BAD 与 大动脉狭窄堵塞穿支;进展机制;The Impact of Diagnosing Branch Atheromatous Disease for Predicting Prognosis;Different Characteristics of Anterior and Posterior BAD with or without END;Predictive factors for progressive motor deficits in penetrating artery infarctions in two different arterial territories;Lipid and hyperglycemia factors in first-everpenetrating artery infarction, a comparison between different subtypes;治疗;Stuttering Lacunes: An Acute Role for Clopidogrel?;Cilostazol for the Prevention of BAD;双抗优于单抗;Treatment of Progressive Stroke withTirofiban – Experience in 35 Patients ;Safety and Preliminary Efficacy of Early TirofibanTreatment After Alteplase in Acute Ischemic Stroke Patients;Safety and Preliminary Efficacy of Early TirofibanTreatment After Alteplase in Acute Ischemic Stroke Patients;;tPA did not adequately prevent END, and did not show better outcome in LSA infarction due to BAD compared with antiplatelet therapy only. ;小结